Form 8-K · Current Report · Filed 2026-08-11
Cardinal Health Enters New $4.0 Billion Credit Agreement and Terminates Existing Facilities
On August 7, 2026, Cardinal Health, Inc. entered into a new unsecured Credit Agreement providing access to $4.0 billion of revolving credit through August 7, 2031, with an option to extend by up to two years. This new agreement replaced the Company's existing Five-Year Credit Agreement, dated February 27, 2023, and its 364-Day Credit Agreement, dated October 7, 2025, both of which were terminated on the same day. Additionally, the Company terminated its Fifth Amended and Restated Receivables Purchase Agreement, dated September 1, 2023, and the Performance Guaranty by the Company in favor of CH-23 Funding. There were no penalties incurred by the Company as a result of the terminations.
- Filer
- Cardinal Health Inc. CAH · NYSE
- Filed
- Accession
- 0000721371-26-000036
- CIK
- 0000721371
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$237.20
Since filing
+0.0%
Latest close
$237.20
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CAH reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, CAH insiders reported 8 Form 4 transactions — flat net activity.
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Never miss another CAH filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.